165 related articles for article (PubMed ID: 37237291)
1. Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy.
Bang C; Park MG; Cho IK; Lee DE; Kim GL; Jang EH; Shim MK; Yoon HY; Lee S; Kim JH
Biomater Res; 2023 May; 27(1):53. PubMed ID: 37237291
[TBL] [Abstract][Full Text] [Related]
2. Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy.
Shim MK; Na J; Cho IK; Jang EH; Park J; Lee S; Kim JH
J Control Release; 2021 Mar; 331():434-442. PubMed ID: 33508352
[TBL] [Abstract][Full Text] [Related]
3. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
[TBL] [Abstract][Full Text] [Related]
4. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.
Fujiwara-Tani R; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Kondoh M; Kuniyasu H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982569
[TBL] [Abstract][Full Text] [Related]
5. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin.
Gao Z; Xu X; McClane B; Zeng Q; Litkouhi B; Welch WR; Berkowitz RS; Mok SC; Garner EI
Clin Cancer Res; 2011 Mar; 17(5):1065-74. PubMed ID: 21123456
[TBL] [Abstract][Full Text] [Related]
6. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.
Yuan X; Lin X; Manorek G; Kanatani I; Cheung LH; Rosenblum MG; Howell SB
Mol Cancer Ther; 2009 Jul; 8(7):1906-15. PubMed ID: 19567823
[TBL] [Abstract][Full Text] [Related]
7. Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway.
Kono T; Kondoh M; Kyuno D; Ito T; Kimura Y; Imamura M; Kohno T; Konno T; Furuhata T; Sawada N; Hirata K; Kojima T
Pharmacol Res Perspect; 2015 Dec; 3(6):e00196. PubMed ID: 27022469
[TBL] [Abstract][Full Text] [Related]
8. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.
Gabig TG; Waltzer WC; Whyard T; Romanov V
Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378
[TBL] [Abstract][Full Text] [Related]
9. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
[TBL] [Abstract][Full Text] [Related]
10. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
11. Role of
Fujiwara-Tani R; Fujii K; Mori S; Kishi S; Sasaki T; Ohmori H; Nakashima C; Kawahara I; Nishiguchi Y; Mori T; Sho M; Kondoh M; Luo Y; Kuniyasu H
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481659
[TBL] [Abstract][Full Text] [Related]
12. Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells.
Yamaguchi H; Kojima T; Ito T; Kyuno D; Kimura Y; Imamura M; Hirata K; Sawada N
Cell Mol Biol Lett; 2011 Sep; 16(3):385-97. PubMed ID: 21573709
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4.
Kyuno D; Kojima T; Ito T; Yamaguchi H; Tsujiwaki M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N
Cell Tissue Res; 2011 Dec; 346(3):369-81. PubMed ID: 22160590
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for
Vecchio AJ; Rathnayake SS; Stroud RM
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876770
[TBL] [Abstract][Full Text] [Related]
15. Immunotoxin-mediated targeting of claudin-4 inhibits the proliferation of cancer cells.
Hashimi SM; Yu S; Alqurashi N; Ipe DS; Wei MQ
Int J Oncol; 2013 Jun; 42(6):1911-8. PubMed ID: 23563899
[TBL] [Abstract][Full Text] [Related]
16. Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas.
Nakashima C; Yamamoto K; Kishi S; Sasaki T; Ohmori H; Fujiwara-Tani R; Mori S; Kawahara I; Nishiguchi Y; Mori T; Kondoh M; Luo Y; Kirita T; Kuniyasu H
Oncotarget; 2020 Jan; 11(4):309-321. PubMed ID: 32064037
[TBL] [Abstract][Full Text] [Related]
17. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.
Michl P; Buchholz M; Rolke M; Kunsch S; Löhr M; McClane B; Tsukita S; Leder G; Adler G; Gress TM
Gastroenterology; 2001 Sep; 121(3):678-84. PubMed ID: 11522752
[TBL] [Abstract][Full Text] [Related]
18. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.
Cocco E; Casagrande F; Bellone S; Richter CE; Bellone M; Todeschini P; Holmberg JC; Fu HH; Montagna MK; Mor G; Schwartz PE; Arin-Silasi D; Azoudi M; Rutherford TJ; Abu-Khalaf M; Pecorelli S; Santin AD
BMC Cancer; 2010 Jul; 10():349. PubMed ID: 20598131
[TBL] [Abstract][Full Text] [Related]
19. Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.
Murakami-Nishimagi Y; Sugimoto K; Kobayashi M; Tachibana K; Kojima M; Okano M; Hashimoto Y; Saji S; Ohtake T; Chiba H
Breast Cancer Res; 2023 Apr; 25(1):41. PubMed ID: 37059993
[TBL] [Abstract][Full Text] [Related]
20. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.
Litkouhi B; Kwong J; Lo CM; Smedley JG; McClane BA; Aponte M; Gao Z; Sarno JL; Hinners J; Welch WR; Berkowitz RS; Mok SC; Garner EI
Neoplasia; 2007 Apr; 9(4):304-14. PubMed ID: 17460774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
